Replies to post #460063 on NorthWest Biotherapeutics Inc (NWBO)

[extrooper]

“the recent $11.5 billion acquisition of Acceleron”. That acquisition shows how ignorant companies can be with financial capital. DCVax-L has so much more potential as the platform it has proven itself to be with combination therapies, yet Merck wastes money on such purchases.

Merck CEO & BOD have shown themselves to only be wasteful with company resources and as devoid of awareness as a drunk.

[MI Dendream]

DD, it is quite interesting that they swapped Opdivo and Keytruda.

I am wishing for a bidding war, but I will settle for Merck.